Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 45 results found. Search for [ Albert Bourla ]

Results 1 to 21 of 45
PB Jayakumar
May 8, 2021
The two m-RNA technology based COVID-19 vaccines are set to shatter the record of Pfizer's Lipitor in terms of highest sales in a year.


BusinessToday.In
New Delhi, May 3, 2021
American pharmaceutical giant Pfizer announced on Monday that it is sending medicines worth $70 million to India. The firm will be sending drugs that have been identified as part of India's COVID-19 treatment protocol, according to Pfizer's Chairman and CEO Albert Bourla. The medicines will come from Pfizer's distribution centres in the US, Europe and Asia. Bourla, in his mail to Pfizer's employees in India, said that his Pfizer colleagues at various distribution centres in the US, Europe and Asia are at work preparing shipments of medicines that have been identified by the Indian government as part of its COVID-19 treatment protocol. Watch the video for more.Also Read: 'No lockdown; division of country into zones': Lancet task force suggests measures to fight COVID-19


Reuters
May 3, 2021
Unfortunately, our vaccine is not registered in India although our application was submitted months ago, Pfizer CEO Albert Bourla said


BusinessToday.In
May 3, 2021
The firm will be sending drugs that have been identified as part of India's COVID-19 treatment protocol, according to Pfizer's Chairman and CEO Albert Bourla.


PTI
April 30, 2021
During the talks, Sandhu appraised the business community of the items that India is trying to identify and source, including oxygen concentrators, cylinders, ventilators and oxygen generation plants and COVID-19-related drugs


BusinessToday.In
April 16, 2021
\"It is extremely important to suppress the pool of people that can be susceptible to the virus,\" said Pfizer CEO Albert Bourla


BusinessToday.In
April 1, 2021
The vaccine was also effective in South Africa, where B.1.351 lineage of the virus is prevalent. It said nine cases of COVID-19 were observed in the country, all in the placebo group.


BusinessToday.In
March 31, 2021
The companies plan to submit the data from the trial to U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of the vaccine.


Reuters
March 23, 2021
The drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WSJ reported, citing an interview with Pfizer Chief Executive Officer Albert Bourla


BusinessToday.In
February 3, 2021
In releasing its fourth-quarter earnings, Pfizer also forecast 2021 sales between $59.4 billion and $61.4 billion. The company raised its full-year earnings guidance to between $3.10 to $3.20 from $3 to $ 3.10 earlier


BusinessToday.In
December 16, 2020
Pfizer Albert Bourla said that Pfizer runs a lot of polls to see what would make people willing to take the vaccine. Bourla added that one of the top responses is if the CEO takes it


Reuters
December 15, 2020
The WHO and GAVI vaccine alliance aim to provide poor and middle-income countries with diagnostic tests, drugs and vaccines through a fund known as the Access to COVID-19 Tools (ACT) Accelerator, which was set up last April


BusinessToday.In
December 15, 2020
A senior official from WHO told Reuters about its talks with both companies to include their coronavirus vaccines as part of an early global rollout


BusinessToday.In
December 9, 2020
\"The fundamental that went into the pricing was that we make sure we make it very quickly available to everyone,\" said Pfizer.


BusinessToday.In
December 9, 2020
Albert Bourla, the CEO of Pfizer, said the company will have tiered pricing for the middle-income countries (including, India) and will give the vaccine free in Africa


BusinessToday.In
December 5, 2020
On December 2, the UK became the first country in the world to approve Pfizer and BioNTech coronavirus candidate BNT162b2 after the Medicines and Healthcare Products Regulatory Agency found the jab safe for widespread rollout


BusinessToday.In
December 3, 2020
However, VK Paul, who heads the National Task Force on COVID-19, had said in November that the arrival of the Pfizer vaccine in India might take months.


Vivek Punj
New Delhi, December 3, 2020
Extend restructuring window till March 2021, banks appeal to RBI The Reserve Bank of India has received a request from the Indian Banks' Association to extend the restructuring window recommended by the KV Kamath committee till March 31, 2021. The recast window is set to lapse on December 31. L&T on track to sell non-core assets to reduce liabilitiesEngineering and construction giant Larsen and Toubro (L&T) is on track to divest its non-core assets to cut its consolidated debt of...


Reuters
December 3, 2020
The UK has already ordered 40 million doses of the Pfizer vaccine to vaccinate its 20 million population, of which around 10 million doses will be available soon


BusinessToday.In
December 2, 2020
The stock has risen 3.32% in the last 2 days of consecutive gain. Market capitalisation of the firm stood at Rs 23,994 crore today


PAGES 1 OF 3  123